Title : PARP inhibitor maintenance therapy for patients with platinum-sensitive recurrent ovarian cancer: a cost-effectiveness analysis.

Pub. Date : 2015 Oct

PMID : 26303225






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 For the 4439 patients with wild-type BRCA, the cost of maintenance therapy was $444.2M; the ICER was $600,552 per PF-LYS. Lysine cAMP responsive element modulator Homo sapiens